Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Push For Rapid Diagnostics, Protective Equipment Amid Flu Outbreak

This article was originally published in The Pink Sheet Daily

Executive Summary

Respirators and other personal protective equipment for health workers treating flu sufferers would be part of a $1.5 billion appropriation President Obama called on Congress to provide through FY 09 supplemental appropriations.

You may also be interested in...



Sebelius HHS Tenure Dominated By ACA Coverage, But Also Focused On Fraud, Transparency

HHS Secretary Kathleen Sebelius is resigning, and Office of Management and Budget Director Sylvia Mathews Burwell has been nominated to take over her cabinet post, President Obama announced April 11.

H1N1 Vaccine Update: Big Sales To Come In Fourth Quarter, Mfrs. Say

The pandemic influenza situation is leaving the biopharmaceutical industry in a healthy state - with early reports of vaccine sales having notable impact on manufacturers' bottom lines, revitalization for waning antiviral products and accelerated pathways for novel products

H1N1 Vaccine Update: Big Sales To Come In Fourth Quarter, Mfrs. Say

The pandemic influenza situation is leaving the biopharmaceutical industry in a healthy state - with early reports of vaccine sales having notable impact on manufacturers' bottom lines, revitalization for waning antiviral products and accelerated pathways for novel products

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS069498

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel